Results 171 to 180 of about 79,137 (281)

Molecular characterization of Th17 lymphocytes and monocyte-derived dendritic cells in the context of HIV-1 infection

open access: yes, 2015
Le virus de l’immunodéficience humaine de type 1 (VIH-1) altère les fonctions du système immunitaire pour promouvoir sa persistance. Les composantes de l’immunité ciblées par le VIH-1 incluent les lymphocytes Th17 et les cellules dendritiques dérivées ...
Wacleche, Vanessa S.
core  

Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy

open access: yesPhytotherapy Research, EarlyView.
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee   +9 more
wiley   +1 more source

Flavonoids in Nasal Therapeutics: Biological Activities, Delivery Challenges, and Formulation Strategies–A Systematic Review

open access: yesPhytotherapy Research, EarlyView.
Overview of the therapeutic potential of flavonoids in nasal delivery systems, highlighting their benefits to the human nasal cavity, and applications in the treatment of respiratory and brain‐related diseases. ABSTRACT Flavonoids represent a significant group of secondary metabolites.
Jeniffer Viviana Ramirez Hernández   +5 more
wiley   +1 more source

Painful Bilateral Necrosis of the Scalp

open access: yes
JEADV Clinical Practice, EarlyView.
Zoé Dumesnil   +6 more
wiley   +1 more source

Mesenchymal stromal cell therapy for rheumatoid arthritis: Long‐term efficacy, safety, and mechanistic insights

open access: yesRheumatology &Autoimmunity, EarlyView.
Graphical abstract summarizing the multifactorial pathogenesis of rheumatoid arthritis (RA) and the therapeutic potential of mesenchymal stromal cell (MSC) therapy. MSCs provide promising benefits through their immunomodulatory properties, low immunogenicity, ability to promote tissue repair, and multi‐lineage differentiation, presenting a potential ...
Yingjia Chen   +6 more
wiley   +1 more source

Induction d'une différentiation en lymphocytes Th17 par le PAF

open access: yes, 2009
Le PAF (Platelet-Activating Factor) est un médiateur reconnu pour son implication dans plusieurs effets physiologiques et pathologiques, particulièrement les états inflammatoires.
Drolet, Anne-Marie
core  

Age‐related clinical heterogeneity and peripheral T cell profile alterations in primary Sjögren's disease: A retrospective study of 5778 patients

open access: yesRheumatology &Autoimmunity, EarlyView.
This large‐scale retrospective study of 5778 primary Sjögren's disease (SjD) patients, stratified by diagnostic age, defines a distinct clinical and immunological profile for early‐diagnosed (<45 years) disease. We identified early diagnosis as an independent risk factor for hypergammaglobulinemia and interstitial lung disease, underpinned by a ...
Yuan Ning   +7 more
wiley   +1 more source

STUDIES OF NATURAL T LYMPHOCYTES : iNKT17 and Th17.

open access: yes, 2012
The thymus is an organ for the development of T lymphocytes, part of the immune system. These cells are commonly associated with the adaptive immune system, although some populations, including Tγδ and iNKT cells, are associated with the innate immune system.
openaire   +1 more source

The evolving role of regulatory T cells in Sjögren's disease pathogenesis and the promise of Treg‐based therapies: A comprehensive review

open access: yesRheumatology &Autoimmunity, EarlyView.
Graphical Abstract The evolving role of regulatory T cells in primary Sjögren's disease pathogenesis and the promise of Treg‐based therapies. Abstract Sjögren's disease (SjD) is a chronic systemic autoimmune disorder characterised by exocrine gland dysfunction and diverse systemic manifestations.
Gagan Urs   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy